SMP-93566
SMP-93566 is a kind of antibody-drug conjugates (ADCs) with a low payload shedding rate and has in vivo tumor inhibitory effects on ovarian cancer, gastric cancer, and breast cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3055605-39-2
- Fòrmula: C72H100N8O21
- Peso molecular:1413.61
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas Drug-Linker Conjugates for ADC
More
Actividad biológica
Descripciòn
In Vitro
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
No. CAS 3055605-39-2
-
Peso molecular 1413.61
-
Fòrmula C72H100N8O21
-
SMILES
O=C(NC[C@@H](O)C[C@H]1O[C@@H](C[C@H]2O[C@@H](CC[C@H]3C(C[C@H](CC[C@]45C[C@](O6)([H])[C@@H]7O4)O3)=C)C[C@@H](C)C2=C)[C@H](CC(C[C@H]8CC[C@@]9([H])[C@]([C@H](O5)C6C7O9)([H])O8)=O)[C@H]1OC)CNC([C@H](CC%10=CC=CC=C%10)NC(CNC(CNC(CN%11CCOCCN(C(CCN%12C(C=CC%12=O)=O)=O)CCOCC%11)=O)=O)=O)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocolo
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
Pureza y Documentación
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)